Bio-Rad Laboratories, Inc.Class A (BIO) is a publicly traded Healthcare sector company. As of July 23, 2026, BIO trades at $274.09 with a market cap of $8.07B and a P/E ratio of 10.97. BIO moved -10.42% today. Year to date, BIO is +0.98%; over the trailing twelve months it is +24.64%. Its 52-week range spans $211.43 to $373.69. Analyst consensus is buy with an average price target of $301.67. Rallies surfaces BIO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Bio-Rad Laboratories, Inc.Class A (BIO) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. BIO moved -10.42% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $274.09 |
| Market Cap | $8.07B |
| P/E Ratio | 10.97 |
| EPS | $27.87 |
| Dividend Yield | 0.00% |
| 52-Week High | $373.69 |
| 52-Week Low | $211.43 |
| Volume | 2.20K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.58B |
| Net Income | $759.90M |
| Gross Margin | 51.87% |
3 analysts cover BIO: 0 strong buy, 1 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $301.67.